21 – 40 of 47
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Cervical cancer prevention among long-term screening non-attendees by vaginal self-collected samples for hr-HPV mRNA detection
(
- Contribution to journal › Article
-
Mark
Detection of HPV mRNA in Self-collected Vaginal Samples Among Urban Ethiopian Women
(
- Contribution to journal › Article
-
Mark
Negative Pressure Wound Therapy (NPWT) in Groin Wounds after Lymphadenectomy in Vulvar Cancer Patients
(
- Contribution to journal › Article
-
Mark
Primary treatment and relative survival by stage and age in vulvar squamous cell carcinoma : A population-based SweGCG study
(
- Contribution to journal › Article
-
Mark
14-type HPV mRNA test in triage of HPV DNA-positive postmenopausal women with normal cytology
(
- Contribution to journal › Article
-
Mark
A multiplex biomarker assay improves the diagnostic performance of HE4 and CA125 in ovarian tumor patients
(
- Contribution to journal › Article
- 2019
-
Mark
Detection of HPV mRNA in Self-collected Vaginal Samples Among Women at 69-70 Years of Age
(
- Contribution to journal › Article
-
Mark
Increased HPV detection by the use of a pre-heating step on vaginal self-samples analysed by Aptima HPV assay
(
- Contribution to journal › Article
-
Mark
Population-based primary HPV mRNA cervical screening compared with cytology screening
(
- Contribution to journal › Article
-
Mark
Primary treatment patterns and survival of cervical cancer in Sweden : A population-based Swedish Gynecologic Cancer Group Study
(
- Contribution to journal › Article
-
Mark
Lymphovascular space invasion as a predictive factor for lymph node metastases and survival in endometrioid endometrial cancer - a Swedish Gynecologic Cancer Group (SweGCG) study
(
- Contribution to journal › Article
- 2018
-
Mark
Lymph node metastases as only qualifier for stage IV serous ovarian cancer confers longer survival than other sites of distant disease – a Swedish Gynecologic Cancer Group (SweGCG) study
(
- Contribution to journal › Article
-
Mark
Confounders other than comorbidity explain survival differences in Danish and Swedish ovarian cancer patients – a comparative cohort study
(
- Contribution to journal › Article
-
Mark
Data quality in the Swedish Quality Register of Gynecologic Cancer – a Swedish Gynecologic Cancer Group (SweGCG) study
(
- Contribution to journal › Article
- 2017
-
Mark
Ovarian cancer surgery - A population-based registry study
(
- Contribution to journal › Article
-
Mark
Risk factors for lymph node metastases in women with endometrial cancer : A population-based, nation-wide register study—On behalf of the Swedish Gynecological Cancer Group
(
- Contribution to journal › Article
-
Mark
Population-based study of survival for women with serous cancer of the ovary, fallopian tube, peritoneum or undesignated origin - on behalf of the Swedish gynecological cancer group (SweGCG)
(
- Contribution to journal › Article
- 2016
-
Mark
A population-based registry study evaluating surgery in newly diagnosed uterine cancer
(
- Contribution to journal › Article
-
Mark
A Biomarker Panel Increases the Diagnostic Performance for Epithelial Ovarian Cancer Type I and II in Young Women
(
- Contribution to journal › Article
- 2015
-
Mark
Age influences the clinical significance of atypical glandular cells on cytology.
(
- Contribution to journal › Article